• Company
• Patent term extensions for advanced biologicals under review
• by Kim, Jin-Gu Sep 20, 2022 05:56am

• Company
• 41 were vaccinated in 11 days with K-COVID-19 vaccines
• by Sep 19, 2022 05:57am

• Opinion
• [Reporter's view] Reform of the innovative system
• by Lee, Jeong-Hwan Sep 19, 2022 05:56am

• Policy
• Empagliflozin's permission changes
• by Lee, Hye-Kyung Sep 19, 2022 05:56am

• Company
• Breast cancer drug Nerlynx can be prescribed
• by Eo, Yun-Ho Sep 19, 2022 05:56am

• Policy
• Drug price negotiation completed 307 drugs in 2022
• by Lee, Tak-Sun Sep 16, 2022 05:53am

• Policy
• “GOV to prove causal relationship of vaccine side effects"
• by Lee, Jeong-Hwan Sep 16, 2022 05:53am

• Opinion
• [Reporter’s View] Evrysdi awaits reimb review for over 1 yr
• by Eo, Yun-Ho Sep 16, 2022 05:53am

• Policy
• The introduction of Moderna COVID-19 vaccine has begun
• by Kim, Jung-Ju Sep 16, 2022 05:53am

• Product
• Benefit standards are the key to the migraine market
• by Whang, byung-woo Sep 16, 2022 05:52am